Literature DB >> 14511412

Continuous glucose monitoring with glucose sensors: calibration and assessment criteria.

Volker Lodwig1, Lutz Heinemann.   

Abstract

Continuous glucose monitoring (CM) by means of minimally invasive or noninvasive glucose sensors can help to further optimize metabolic control in patients with diabetes without need for frequent capillary blood glucose measurements. Most glucose sensors measure glucose concentration in the interstitial fluid (ISF). Because of the varying conditions in this compartment, a general in vitro calibration ( = factory calibration) by the manufacturer appears not to be possible. Therefore, calibration of the sensor signal must be performed by the patient himself repeatedly. The calibration procedure can be performed by means of conventional capillary blood glucose measurements in order to transform the sensor signals obtained from the specific compartment (e.g., ISF) into "blood" glucose values. A number of aspects can influence the validity of this procedure. The relationship between changes in blood glucose and in ISF glucose, in both time and concentration dimensions, is not well understood, especially during dynamic changes. The physical lag time, which critically depends on the glucose sensor technology used, can also introduce a systematic calibration error. After the first calibration, usually performed some hours after the application of a given glucose sensor, recalibration at certain intervals is necessary. Therefore, patients should critically assess the values displayed by a CM system. In the case of implausible glucose values they should verify the results by means of a conventional capillary glucose measurement. Up to now there is no consensus on assessment criteria to be used for evaluation of CM system performance and calibration quality. Existing methods of displaying CM values against corresponding reference values, including linear regression analysis and error grid analysis, as well as numeric criteria such as System Error, Predicted Error Sum of Squares (in %), and Mean Absolute Deviation are not generally applicable to CM. It appears as if they do not allow sufficient description of data obtained with CM systems. There is a pressing need to develop novel adequate assessment criteria enabling a better characterization of CM system performance. If these were used uniformly by all manufacturers and scientists assessing CM systems, this would allow a fair comparison of the performance of different systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511412     DOI: 10.1089/152091503322250596

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  25 in total

1.  Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms.

Authors:  B Wayne Bequette
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

Review 2.  Technologies for continuous glucose monitoring: current problems and future promises.

Authors:  Santhisagar Vaddiraju; Diane J Burgess; Ioannis Tomazos; Faquir C Jain; Fotios Papadimitrakopoulos
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 3.  Current problems and potential techniques in in vivo glucose monitoring.

Authors:  Y Wickramasinghe; Y Yang; S A Spencer
Journal:  J Fluoresc       Date:  2004-09       Impact factor: 2.217

4.  Modeling the error of continuous glucose monitoring sensor data: critical aspects discussed through simulation studies.

Authors:  Andrea Facchinetti; Giovanni Sparacino; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

5.  Statistical approach of assessing the reliability of glucose sensors: the GLYCENSIT procedure.

Authors:  Tom Van Herpe; Kristiaan Pelckmans; Jos De Brabanter; Frizo Janssens; Bart De Moor; Greet Van den Berghe
Journal:  J Diabetes Sci Technol       Date:  2008-11

6.  Numerical simulation of the effect of rate of change of glucose on measurement error of continuous glucose monitors.

Authors:  Marc B Taub; Thomas A Peyser; J Erik Rosenquist
Journal:  J Diabetes Sci Technol       Date:  2007-09

7.  On-chip microdialysis system with flow-through glucose sensing capabilities.

Authors:  Yi-Cheng Hsieh; Jeffrey D Zahn
Journal:  J Diabetes Sci Technol       Date:  2007-05

8.  Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.

Authors:  Werner Regittnig; Stefan Lindpointner; Stefan Korsatko; Dina Tutkur; Manfred Bodenlenz; Thomas R Pieber
Journal:  Diabetes Technol Ther       Date:  2012-11-05       Impact factor: 6.118

9.  Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.

Authors:  Enrique Campos-Náñez; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2017-05-31

10.  Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Ruthy Kaidar; Ofer Yodfat; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.